Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cerimon Pharmaceuticals, a biopharmaceutical company engaged in the development of therapeutic products for pain and inflammation, has appointed James Shannon to its board of directors.
Subscribe to our email newsletter
Most recently, Dr Shannon has served as head of global development at Novartis Pharma in Basel, Switzerland. Dr Shannon has received his undergraduate and postgraduate degrees from Queen’s University of Belfast, where he was trained in medicine and cardiology.
Paul Sekhri, CEO of Cerimon Pharmaceuticals, said: “We are thrilled to welcome Dr Shannon to our board of directors. Dr Shannon’s expertise in identifying and advancing drug development candidates will be of great value as we seek to expand and deepen Cerimon’s clinical-stage pipeline.”